» Articles » PMID: 37194004

Efficacy of Perioperative Duloxetine As a Part of Multimodal Analgesia in Laparoscopic Colorectal Cancer Surgeries

Overview
Journal BMC Anesthesiol
Publisher Biomed Central
Specialty Anesthesiology
Date 2023 May 16
PMID 37194004
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although laparoscopic surgery provides earlier recovery, less morbidity and hospital stay, however, severe pain is still a problem after it. Duloxetine has been recently used in postoperative pain management. We tested perioperative duloxetine to evaluate its effect on patients undergoing laparoscopic colorectal cancer surgery.

Methods: Sixty patients were enrolled in this study divided into two equal groups; duloxetine group each patient received an oral duloxetine capsule (60 mg) 1st dose at night before surgery, the 2nd dose 1 h preoperative, and the 3rd dose 24 h postoperative. Placebo group received placebo capsules at the same times. The cumulative morphine consumption in 48 h, postoperative VAS score, quality of recovery (QoR-40 score), sedation, and adverse effects were evaluated.

Results: Duloxetine group had lower VAS scores compared to placebo group, (3 ± 0.69) VS. (4.17 ± 0.83), (2.5 ± 0.6) VS. (4.3 ± 0.9), (2.2 ± 0.7) VS. (3.9 ± 0.6), (1.6 ± 0.7) VS. (3.6 ± 0.8), (1.1 ± 0.8) VS. (3.7 ± 0.7), (0.7 ± 0.7) VS. (3.5 ± 0.8), (0.6 ± 0.7) VS. (3.5 ± 0.8) respectively, P ˂0.01. The cumulative morphine consumption was significantly reduced in the Duloxetine group compared to the placebo group (4.6 ± 2.9 vs. 11.3 ± 1.7 mg), P < 0.01. The total QoR-40 score for duloxetine group was (180.8 ± 4.5) vs. (156 ± 5.9) in placebo group (P < 0.01). Patients in Duloxetine group were more sedated in all the 48 h postoperatively in comparison to placebo group.

Conclusions: Perioperative duloxetine had reduced postoperative pain, decreased opioid consumption, and improved the quality of recovery in patients undergoing laparoscopic colorectal surgery.

References
1.
El-Sherbiny W, Saber W, Askalany A, El-Daly A, Sleem A . Effect of intra-abdominal instillation of lidocaine during minor laparoscopic procedures. Int J Gynaecol Obstet. 2009; 106(3):213-5. DOI: 10.1016/j.ijgo.2009.04.016. View

2.
Buchanan F, Myles P, Cicuttini F . Effect of patient sex on general anaesthesia and recovery. Br J Anaesth. 2011; 106(6):832-9. DOI: 10.1093/bja/aer094. View

3.
Gornall B, Myles P, Smith C, Burke J, Leslie K, Pereira M . Measurement of quality of recovery using the QoR-40: a quantitative systematic review. Br J Anaesth. 2013; 111(2):161-9. DOI: 10.1093/bja/aet014. View

4.
Fuad Hetta D, Elgalaly N, Mohammad M . The Efficacy of Preoperative Duloxetine in Patients Undergoing Major Abdominal Cancer Surgery: A Randomized Controlled Trial. Clin J Pain. 2021; 37(12):908-913. DOI: 10.1097/AJP.0000000000000983. View

5.
Iyengar S, Webster A, Hemrick-Luecke S, Xu J, Simmons R . Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther. 2004; 311(2):576-84. DOI: 10.1124/jpet.104.070656. View